Navigate
X
    QualityStocks
  • 18 years ago

ArQule, Inc. (NASDAQ: ARQL)

ArQule, Inc. (NASDAQ: ARQL), a biotechnology company, is committed to researching and developing next-generation, small-molecule cancer therapeutics. The company’s lead product, ARQ 197, is currently in clinical-stage development. ArQule’s discovery efforts are focused on identifying novel kinase inhibitors that are potent, selective and do not compete with ATP (adenosine triphosphate), an energy source for cells. For further information, visit the Company’s web site at www.arqule.com.

Tags Rodman & Renshaw
Related Post
  1. Quantum BioPharma Ltd. (NASDAQ: QNTM) Pursues a New Path for Better Multiple Sclerosis Treatments

    In the United States alone, close to one million people are living with MS, with…

  2. Why Verbal Skills Aren’t Enough: WRAP’s New Doctrine Aims to Give Officers a Lawful Next Step

    California's SB 230 requires agencies to incorporate de-escalation and alternatives to force into their use-of-force…

  3. Beeline Holdings Inc. (NASDAQ: BLNE) Partners with Loft 100 Studios to Examine the Mortgage Market and New Approaches to Homeownership

    The partnership will focus on the production of a 45-minute “Bizumentary” examining current challenges and…